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Alleles of a Polymorphic ETV6 Binding Site in DCDC2
Confer Risk of Reading and Language Impairment
Natalie R. Powers,1 John D. Eicher,1 Falk Butter,3 Yong Kong,4,5 Laura L. Miller,6 Susan M. Ring,6
Matthias Mann,3 and Jeffrey R. Gruen1,2,7,*
Reading disability (RD) and language impairment (LI) are common learning disabilities that make acquisition and utilization of reading
and verbal language skills, respectively, difficult for affected individuals. Both disorders have a substantial genetic component with com-
plex inheritance. Despite decades of study, reading and language, like many other complex traits, consistently evade identification of
causative and functional variants. We previously identified a putative functional risk variant, named BV677278 for its GenBank acces-
sion number, for RD in DCDC2. This variant consists of an intronic microdeletion and a highly polymorphic short tandem repeat (STR)
within its breakpoints. We have also shown this STR to bind to an unknown nuclear protein with high specificity. Here, we replicate
BV677278’s association with RD, expand its association to LI, identify the BV677278-binding protein as the transcription factor
ETV6, and provide compelling genetic evidence that BV677278 is a regulatory element that influences reading and language skills.
We also provide evidence that BV677278 interacts nonadditively with KIAA0319, an RD-associated gene, to adversely affect several
reading and cognitive phenotypes. On the basis of these data, we propose a new name for BV677278: ‘‘READ1’’ or ‘‘regulatory element
associated with dyslexia 1.’’Introduction
Specific learning disabilities (LDs) are disorders character-
ized by unexpected difficulty with a specific mode of
learning, despite adequate intelligence and educational
opportunity. LDs can involve reading, math, writing, and
speech skills, among others, but themost common involve
language. The National Institute of Child Health and
Development (NICHD) estimates that as many as 15%–
20% of Americans might be affected by an LD (NICHD
website, see Web Resources), of which reading disability
(RD) is the most common.1 RD, also known as dyslexia
(MIM 600202), is a specific impairment in processing writ-
ten language.2 Another LD, language impairment (LI [MIM
606711]), is characterized by difficulty processing and
expressing spoken language.3 These LDs are frequently
comorbid, and children with LI have an increased risk of
developing RD.3 Because reading and language skills are
fundamental to academic success, affected individuals are
at risk for adverse psychological outcomes, as well as
limited educational and occupational prospects.2 Addi-
tionally, the prevalence of these LDs makes the cost of
remediation burdensome to the educational system
(National Center for Education Statistics website, see Web
Resources). Intervention is more effective the earlier it is
administered,2 making early detection of high-risk individ-
uals an attractive prospect.
Both RD and LI have a substantial genetic component,
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Thetrait.3,4 Linkage and candidate-gene studies have identified
risk loci and genes for RD and LI but have provided little
insight into molecular mechanisms. The most replicated
RD locus is the ~1.5 Mb DYX2 locus in chromosomal re-
gion 6p22; both linkage and association studies have
repeatedly confirmed its involvement in RD.4 Intriguingly,
two of the most validated RD-associated genes, DCDC2
(MIM 605755) and KIAA0319 (MIM 609269), reside in
DYX2 within 150 kb of each other.4 Variants in both genes
have been associated with RD in multiple independent
genetic studies.4 Likewise, both genes have been shown
via in utero RNAi knockdown studies to be involved in
neuronal migration during development,5,6 although the
extent of their importance in humans is unknown. Aber-
rant neuronal migration, however, is hypothesized to be
a principal pathophysiology underlying RD.7 DCDC2, a
member of the doublecortin gene family, encodes a micro-
tubule-binding protein. Rare mutations in one of its ances-
tral paralogs, DCX (MIM 300121), cause the Mendelian
neuronal migration disorder X-linked lissencephaly (MIM
300067).8 KIAA0319 encodes a transmembrane protein
whose function is currently unknown but that is thought
to have a role in signaling.9 In 2005, we reported in intron
2 ofDCDC2 a 2,445 bpmicrodeletion with a putative func-
tional element within its breakpoints.10 This element
(GenBank accession number BV677278) is a highly poly-
morphic, purine-rich, compound short tandem repeat
(STR). In the 2005 study, we showed that when the micro-
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alleles, this ‘‘compound allele’’ showed strong association
with an endophenotype for RD. That study unfortunately
lacked the power to assess most of the BV677278 alleles
individually as a result of their low allele frequencies, leav-
ing open the question of whether themicrodeletion or one
or more of the BV677278 alleles was responsible for the
signal. Subsequent association studies of themicrodeletion
have been inconclusive,11–13 and until now, only one has
been undertaken for BV677278, but it did not find evi-
dence of association.11 However, we recently showed that
BV677278 binds a brain-expressed nuclear protein with
very high specificity and that it is capable of modulating
reporter-gene expression from the DCDC2 promoter in
an allele-specific manner.14 We also recently showed
that activation patterns in reading-related areas of the
brain, as measured by functional MRI, are influenced by
BV677278 alleles.15
It is currently unknown whether variants in DCDC2,
KIAA0319, both, or neither are responsible for the DYX2
signal—principally because of a lack of power in previous
studies. To address this question, we designed a tagSNP
panel to densely cover the DYX2 locus and performed
haplotype-based association analysis of reading and lan-
guage in a large, extensively phenotyped birth cohort:
the Avon Longitudinal Study of Parents and Children
(ALSPAC).16,17 This analysis revealed that in the same six-
marker haplotype block, one haplotype associates with
impaired reading ability and another associates with
impaired language ability. Both of these haplotypes are in
very strong linkage disequilibrium with an allele of
BV677278. We also used SILAC (stable isotope labeling of
amino acids in cell culture)-based mass spectrometry and
ChIP (chromatin immunoprecipitation) to identify the
BV677278-binding protein as the potent transcriptional
regulator ETV6. Our results replicate and expand the previ-
ous association between BV677278 and reading and now
language, provide strong circumstantial evidence that
BV677278 is a regulatory element that exerts its effect
through ETV6, and show that at least two of its alleles
confer risk of a deleterious effect on reading and language.
We also show that these two BV677278 ‘‘risk alleles’’
interact genetically with a known RD risk haplotype in
KIAA0319 in a nonadditive manner to influence reading,
language, and IQ. Because BV677278 has these effects,
we have renamed it ‘‘READ1,’’ which stands for ‘‘regulatory
element associated with dyslexia 1.’’ It will be referred to
hereafter in this paper as READ1.Material and Methods
Subjects, Subject Recruitment, Data and DNA
Collection, and Data Management
Subject recruitment and collection of phenotype data andDNA for
the ALSPAC cohort was done by the ALSPAC team, as described
elsewhere.17 A detailed description of the phenotypes used in
this study is available in Table S1, available online. The ALSPAC
is a prospective birth cohort based in the Avon region of the20 The American Journal of Human Genetics 93, 19–28, July 11, 2013United Kingdom. It consists mainly of children of northern Euro-
pean descent and born in 1991 and 1992. Children were recruited
before birth; recruitment of their pregnant mothers resulted in a
total of 15,458 fetuses, of whom 14,701 were alive at 1 year of
age. Details regarding the participants, recruitment, and study
methodologies are described in detail elsewhere (see Web
Resources).17 The children of the ALSPAC cohort have been exten-
sively phenotyped from before birth to early adulthood. An
update on the status of the cohort was published recently.17 The
reading, language, and cognitive measures used for this study
were collected when the children were 7, 8, and 9 years old.
DNA samples from 10,259 of these children were available for
genotyping, and of this subset, the number of children who
completed the language and cognitive measures varies by measure
but is generally 5,200–5,600 subjects.
Ethical Approval
Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee, the local UK research ethics commit-
tees, and the Yale Human Investigation Committee. Informed
consent for the study was obtained by the ALSPAC team.16
DYX2 TagSNP Panel Design and Genotyping
TagSNPs designed to capture the common variation in the DYX2
locus were selected with the association study design server of
Han et al. (see Web Resources).18 SNPs were genotyped on the
Sequenom platform in collaboration with the Yale Center for
Genome Analysis as per standard protocols. The call rate and
descriptive statistics for the SNPs reported in this article are listed
in Table S3. rs4504469, rs2038137, and rs2143340were genotyped
by Scerri et al. as previously described.19
Haplotype-Based Association Analysis
Linkage disequilibrium was assessed and haplotypes were defined
with Haploview version 4.2.20 Markers that deviated substantially
from Hardy-Weinberg equilibrium or that had a call rate < 85%
were not used for haplotype analysis. We used the four-gamete-
rule option in Haploview to demarcate haplotype blocks, which
resulted in 44 haplotype blocks covering the DYX2 locus. We per-
formed association analysis with individual haplotypes that had
frequencies of 0.01 or greater (208 total) by using PLINK version
1.07.21 Individuals who did not identify as non-Hispanic white,
who had a total IQ below 75, or whose DNA sample returned an
average call rate below 85% for SNPs that passed quality control
were excluded from association analysis. To correct for multiple
testing, we applied a Bonferroni correction with the alpha level
set at 0.05 and treated each of the 208 haplotypes as an individual
test; the threshold level was therefore 0.05/208 ¼ 2.4038 3 104.
READ1 Genotyping
Individuals who were positive for the DCDC2 haplotypes of inter-
est and could be phased unequivocally (with PLINK’s –hap-phase
function) were genotyped for the READ1 STR. READ1 was
genotyped by PCR amplification, purification of PCR products
with ExoSAP-IT enzyme mix, and Sanger sequencing. Sanger
sequencing was performed at the YaleW.M. Keck DNA Sequencing
Facility as per their standard sequencing protocol. Alleles were
called by an in-house C language program developed for this
purpose. Primer sequences and details of the amplification reac-
tion are shown in Tables S8–S10. The allele-calling program is
available upon request.
Microdeletion Genotyping
Individuals with the DCDC2 haplotypes of interest were also
genotyped for the 2,445 bpDCDC2microdeletion described previ-
ously.10 This naturally occurring deletion encompasses the entire
READ1 STR within its breakpoints, so it must be genotyped in
addition to READ1 so that an accurate genotype can be achieved
for apparent READ1 homozygotes. The microdeletion was geno-
typed by allele-specific PCR and agarose-gel electrophoresis with
the use of a three-primer reaction that generates a ~600 bp ampli-
con from intact chromosomes and a ~200 bp amplicon from chro-
mosomes with the deletion, allowing heterozygotes and both
homozygotes to be readily distinguishable from one another.
PCR products were electrophoresed on 1% agarose gels with the
use of standard 1X TBE buffer with ethidium bromide (0.2 mg/
ml) via standard methods at 100–150 V, depending on gel size.
Gels were imaged on a UV transilluminator and documented
with a Bio-Rad Gel Doc XR imaging system. Genotypes were called
from the gels manually. Primer sequences and details of the ampli-
fication reaction are shown in Tables S8–S10.Protein Identification by SILAC-Based Mass
Spectrometry
Raji (human Burkitt lymphoma, ATCC CCL-86) and HeLa S3
(human cervical carcinoma, ATCC CCL-2.2) cells were SILAC
labeled with Lys8 and Arg10 (Eurisotop) or their naturally occur-
ring counterparts, Lys0 and Arg10 (Sigma), respectively, as
described.22 Heavy nuclear lysate prepared from these cells was
incubated with a biotinylated oligonucleotide probe that was
identical to a READ1 segment and that had been previously shown
to bind a nuclear protein with high specificity.14 Light nuclear
lysate was incubated with a biotinylated scrambled probe previ-
ously shown not to bind the nuclear protein of interest.14 The re-
sulting oligonucleotide-protein complexes were pulled down with
streptavidin-conjugated beads and subjected to quantitative mass
spectrometry, as described previously.23 The reverse experiment
was also done (binding probe with light lysate and scrambled
probe with heavy lysate), resulting in the two-dimensional inter-
action plots in Figures 2A and 2B. Details are described below.
Raji cells were labeled for at least eight generations in DMEM
(-Arg, -Lys) medium containing 10% dialyzed fetal bovine serum
(GIBCO) supplemented with 58 mg/l 13C615N4 L-arginine and
34mg/l 13C615N2 L-lysine (Eurisotop) or the corresponding non-
labeled amino acids. For Raji, cell extracts were prepared as
described in Wu et al.24 HeLa S3 cells were SILAC labeled in
RPMI 1640 (-Arg, -Lys) medium containing 10% dialyzed fetal
bovine serum (GIBCO) supplemented with 84 mg/l 13C615N4
L-arginine and 40 mg/l 13C615N2 L-lysine (Eurisotop) or the
corresponding nonlabeled amino acids. For HeLa S3, three consec-
utive batches of cells were independently harvested and cell ex-
tracts were prepared as described by Dignam et al.25 SILAC, DNA
pull-down of proteins, and quantitative mass spectrometry were
performed as previously described22 with the Raji and HeLa cell
lines. The binding pull-down probe was a concatamer of two
copies of the EMSA3 probe used in the EMSA experiments we re-
ported in 2011, and the scrambled probe was a concatamer of
two copies of the EMSA3-Scram1 probe from the same experi-
ments.14 The sequences of the oligonucleotides we used to make
these probes are shown in Table S11. Twenty-five micrograms of
annealed, concatenated, and desthiobiotinylated DNA probes
was bound to 75 ml of Dynabeads MyOne C1 (Life Technologies).
Excess oligonucleotides were removed, and beads were incubatedThewith 400 mg of SILAC-labeled nuclear extracts in protein-binding
buffer (150 mM NaCl, 50 mM Tris-HCl [pH 8], 0.5% NP-40,
10 mM MgCl2, protease inhibitor cocktail; Roche). After 1 hr on
a rotation wheel at 4C, the beads were washed three times and
combined, and DNA-protein complexes were eluted in protein
binding buffer containing 16 mM biotin. The supernatant was
precipitated with 4 v/v of ethanol overnight, and the proteins
were pelleted by maximum centrifugation on a table-top micro-
centrifuge. The pellet was resolubilized in a solution of 8 M urea
and 50 mM Tris (pH 8.0), reduced with 1 mM DTT, alkylated
with 3 mM iodoacetamide, and subsequently digested with
trypsin (Promega) in 50 mM ammonium bicarbonate buffer
(pH8) at room temperature overnight. Samples were stored on
stage tips and eluted prior to use. Peptides were separated with a
140 min gradient from 5% to 60% acetonitrile (EasyHPLC,
Thermo Fisher) with a 75 mm 15 cm capillary packed with
3.0 mmC18 beads (Dr. Maisch) directlymounted to a LTQ-Orbitrap
mass spectrometer (Thermo Fisher). The instrument was operated
in a data-dependent top-ten acquisitionmodus. The raw data were
searched with the MaxQuant software (version 1.2.0.18) suite
against the complete International Protein Index human database
(version 3.68; 87,061 entries). Enzyme search specificity was
trypsin/p with two allowed miscleavages. Carbamidomethylation
was set as fixed modification, whereas methionine oxidation and
protein N-acetylation were considered variable modifications. The
search was performed with an initial mass tolerance of 7 ppmmass
accuracy for the precursor ion and 0.5 Da for the tandem-mass-
spectrometry spectra.
ChIP-qPCR
To perform the ChIP assays reported in this article, we used the
AbCamChIP kit (catalog # ab500) according to the manufacturer’s
instructions but with several modifications. Themodified protocol
is available upon request. We used 5 mg of a-ETV6 antibody
(sc-166835X, Santa Cruz Biotech) per reaction and 2 mg of control
a-H3 antibody (ab1791, Abcam) per reaction. For quantitative PCR
(qPCR), we used the QIAGENQuantiTect SYBR Green qPCR kit for
ChIP with qPCR (ChIP-qPCR) and followed the manufacturer’s
instructions. We used 25 pg of template per reaction and per-
formed all reactions in triplicate. Primer sequences and details of
the amplification reaction are shown in Tables S8–S10. Quality-
control data for qPCR are shown in Figure S3. We calculated fold
enrichment with respect to the no-antibody control (a complete
ChIP reaction with only beads and no antibody) by raising 2 to
the negative power of the difference between the cycle threshold
(Ct) of an experimental condition (Ct Exp) and its respective no-
antibody control (Ct NoAntibody):
fold enrichment ¼ 2½Ct Exp  Ct NoAntibody:
Results
Two Six-Marker Haplotypes in DCDC2 Are Associated
with Reduced Performance on Reading and Language
Measures
During our analysis, we discovered a six-marker haplotype
block within DCDC2; in this block, two haplotypes—
CGCGAG and GACGAG—associated with very poor per-
formance on a phoneme-deletion task and a composite
language measure, respectively (Table 1). For this analysis,American Journal of Human Genetics 93, 19–28, July 11, 2013 21
Table 1. Association and Linkage-Disequilibrium Data for DCDC2
Risk Haplotypes
Haplotype
CGCGAG GACGAG
Association Data
Phenotype phoneme-deletion task (RD) WOLD-NWR (LI)
Cases (n) 89 270
Controls (n) 5,225 5,240
Haplotype frequency 0.0236 0.0364
Odds ratio 3.20 1.91
p value 6.068 3 105 2.84 3 104
Linkage-Disequilibrium Data
Individuals (n) 226 392
% allele 5 92.0 12.0
% allele 6 7.5 77.6
% clade 1 94.3 91.3
Phenotypes are described in Table S1. Cases are defined by a score of%2 SDs
below the mean. p values that survived Bonferroni correction for multiple
testing (a ¼ 0.05) are bolded. ‘‘% allele 5’’ and ‘‘% allele 6’’ mean the percent-
age of individuals who were positive for the denoted haplotype and also had at
least one copy of the denoted allele or group of alleles. Clade 1, the phyloge-
netic allele branch that includes alleles 5 and 6, is described in Figure S1.we defined RD cases as individuals scoring R2 SDs below
the mean on the phoneme-deletion task and LI cases as
individuals scoring R2 SDs below the mean on either
of two language measures, WOLD (Wechsler Objective
Learning Dimensions) or NWR (nonword repetition). The
phoneme-deletion task measures phonological awareness,
which is widely considered to be the core deficit in RD.2
The WOLD verbal comprehension and NWR tasks that
comprise the WOLD-NWR composite language measure
are used for assessing deficient language skills; children
with LI show consistently poor performance on these
measures26,27 (see Table S1 for more information on these
phenotypic measures). We defined cases in this way to
examine association between DYX2 haplotypes and severe
RD and LI. The two haplotypes showed strong association
with their respective phenotypes; the association between
CGCGAG and RD survived Bonferroni correction for mul-
tiple testing, and the GACGAG-LI p value was just below
the threshold. However, the associations by themselves
were not strong enough to rule out type 1 error, partly
because of the low frequencies of the haplotypes and
the low number of cases. Interestingly, however, the effect
of these haplotypes was strong enough to significantly
reduce mean performance on relevant phenotypic mea-
sures. Compared with CGCGAG-negative individuals,
CGCGAG-positive individuals, on average, showed signif-
icantly poorer performance on eight reading-related mea-
sures. Likewise, relative to GACGAG-negative individuals,
GACGAG-positive individuals showed significantly lower
mean performance on the WOLD-NWR composite lan-22 The American Journal of Human Genetics 93, 19–28, July 11, 2013guage measure (Table 2). This quantitative effect indicated
to us that this finding is not a false positive and prompted
us to pursue it further. Additionally, this haplotype block
resides on the chromosome in close proximity to READ1,
a putatively functional compound STR we reported previ-
ously as BV67727810 (Figure 1B). The polymorphism of
READ1 is derived from five discrete repeat units that vary
in number (Figure 1A and Table S4). Like many repetitive
elements, this STR appears to evolve rapidly, as indicated
by its high degree of polymorphism among primate species
and within Homo sapiens (Figure 1C, Figure S2, and Table
S4). Although the risk haplotype block is close to READ1,
and therefore to the 2,445 bp DCDC2 microdeletion
when it is present, the SNPs that compose it all lie outside
the deleted region. The integrity of this haplotype block is
therefore unaffected by the presence of the microdeletion,
which for the purpose of this analysis we treated as an
additional allele of READ1.
The DCDC2 Risk Haplotypes Show Strong Linkage
Disequilibrium with Two Alleles of READ1
Because the associated haplotype block is adjacent to
READ1 (Figure 1B), we questioned whether the two risk
haplotypes could be capturing association arising from
functional READ1 alleles via linkage disequilibrium. To
address this question, we subjected all individuals positive
for these haplotypes to READ1 genotyping by Sanger
sequencing. Of the CGCGAG-positive subjects, 92% were
also positive for READ1 allele 5. Likewise, 78% of
GACGAG-positive subjects were also positive for READ1
allele 6 (Table 1). Alleles 5 and 6 are similar in structure
to each other and cluster phylogenetically to the same
clade (Table S4 and Figure S1). Indeed, the genomes of
nearly all individuals positive for one of these two haplo-
types also harbored an allele from this clade (Table 1).
These results further implicate READ1 as a RD risk variant
and expand it as a possible LI risk variant10 and, together
with its apparent regulatory capacity,14 suggest that these
READ1 alleles are responsible for the risk haplotypes’
effects.
READ1 Specifically Binds the Transcription Factor
ETV6
To gain mechanistic insight into the function of READ1,
we used quantitative mass spectrometry to identify the
protein(s) that bind to this locus.22 To this end, we incu-
bated both a biotinylated oligonucleotide probe (with
sequence derived from the READ1 STR) that we previously
showed to bind a nuclear protein and a scrambled
nonbinding control probe with nuclear extracts that had
been SILAC labeled (Table S11).14 SILAC labeling involves
culturing two parallel populations of cells—one with
media containing amino acids labeled with heavy isotopes
of carbon and nitrogen and the other with naturally occur-
ring isotopes. After the label is incorporated, proteins from
the two populations (‘‘heavy’’ and ‘‘light’’) can be differen-
tiated from each other by quantitative mass spectrometry.
Table 2. Mean Performance on Reading and Cognitive Measures in Individuals Positive for and Negative for the DCDC2 Risk Haplotype
Reading or Cognitive Measure
Mean Performance (SD)
CGCGAG (RD) Haplotype GACGAG (LI) Haplotype
Positive Negative p Value Positive Negative p Value
Reading at 7 years 27.34 (9.04) 29.01 (8.77) 0.005* 29.09 (8.62) 28.92 (8.80) 0.728
n ¼ 232 n ¼ 929 n ¼ 358 n ¼ 4,803
Spelling at 7 years 24.38 (13.46) 26.29 (12.33) 0.023* 25.56 (12.77) 26.26 (12.36) 0.305
n ¼ 229 n ¼ 4,896 n¼ 355 n ¼ 4,770
Phoneme-deletion task 19.30 (10.00) 20.80 (9.17) 0.016* 20.61 (9.20) 20.74 (9.21) 0.796
n ¼ 230 n ¼ 4,909 n ¼ 357 n ¼ 4,782
Reading at 9 years 7.37 (2.71) 7.73 (2.27) 0.020* 7.75 (2.33) 7.72 (2.29) 0.754
n ¼ 228 n ¼ 4,914 n ¼ 359 n ¼ 4,783
NW reading at 9 years 5.05 (2.58) 5.38 (2.36) 0.043* 5.47 (2.36) 5.36 (2.44) 0.391
n ¼ 228 n ¼ 4,911 n ¼ 359 n ¼ 4,780
Spelling at 9 years 10.03 (2.58) 10.50 (3.23) 0.031* 10.48 (3.25) 10.48 (3.26) 0.987
n ¼ 228 n ¼ 4,904 n ¼ 357 n ¼ 4,775
Speed 105.44 (11.76) 106.34 (12.10) 0.299 106.71 (11.77) 106.27 (12.11) 0.524
n ¼ 207 n ¼ 4,430 n ¼ 326 n ¼ 4,311
Accuracy 102.77 (14.00) 105.22 (13.10) 0.009* 105.18 (13.24) 105.11 (13.15) 0.919
n ¼ 208 n ¼ 4,438 n ¼ 329 n ¼ 4,317
Reading comprehension 99.74 (11.67) 101.54 (11.37) 0.026* 101.73 (11.82) 101.44 (11.35) 0.663
n ¼ 208 n ¼ 4,438 n ¼ 329 n ¼ 4,317
Verbal IQ 107.35 (15.70) 108.97 (15.67) 0.113 108.38 (15.90) 108.94 (15.65) 0.497
n ¼ 245 n ¼ 5,334 n ¼ 388 n ¼ 5,191
Performance IQ 101.23 (14.96) 100.28 (16.16) 0.366 101.10 (15.72) 101.19 (16.14) 0.913
n ¼ 245 n ¼ 5,334 n ¼ 388 n ¼ 5,191
Total IQ 104.58 (14.22) 106.05 (15.26) 0.138 105.62 (14.95) 106.01 (15.23) 0.623
n ¼ 245 n ¼ 5,334 n ¼ 388 n ¼ 5,191
NWR 7.54 (1.94) 7.58 (1.91) 0.724 7.40 (1.91) 7.55 (1.91) 0.136
n ¼ 245 n ¼ 5,276 n ¼ 384 n ¼ 5,137
WOLD 7.11 (2.56) 7.33 (2.44) 0.178 7.12 (2.60) 7.33 (2.43) 0.104
n ¼ 245 n ¼ 5,270 n ¼ 383 n ¼ 5,132
NWR-WOLD 0.031 (0.82) 0.00 (0.78) 0.532 0.08 (0.77) 0.01 (0.78) 0.041*
n ¼ 245 n ¼ 5,281 n ¼ 384 n ¼ 5,142
The SD is shown in parentheses next to each mean. The number of subjects in each category is shown below each mean. The p values are from Student’s t tests
comparing the means of individuals positive for and negative for each haplotype; p values less than 0.05 are marked with an asterisk. Phenotypes are described in
Table S1. Abbreviations are as follows: NW, nonword; NWR, nonword-repetition task; WOLD, Wechsler Objective Learning Dimensions verbal comprehension
task; and NWR-WOLD, the average Z score of performance on NWR and WOLD verbal comprehension tasks.We incubated the heavy nuclear extract with the READ1
probe and incubated the light nuclear extract with the con-
trol probe. We then pulled down the probes with streptavi-
din-conjugated beads, subjected the resulting protein
mixture to quantitative mass spectrometry, and looked
for proteins significantly enriched by pull-down with the
READ1 probe compared to the control probe (high
heavy-to-light ratio). The experiment was conductedThewith nuclear extracts derived from either HeLa cells or
Raji cells and was repeated with a label switch resulting
in a two-dimensional interaction plot. These experiments
yielded a single candidate shared by both HeLa and Raji
cells: the transcription factor ETV6 (Figures 2A and 2B).
To confirm the READ1-ETV6 interaction, we performed
ChIP-qPCR by using a-ETV6 antibody in both the Raji
cell line and the human neuroepithelioma cell lineAmerican Journal of Human Genetics 93, 19–28, July 11, 2013 23
Figure 1. READ1 Is a Highly Polymorphic STR Located Near the DCDC2 Risk Haplotype Block
(A) Structure of the READ1 STR.
(B) Location of theDCDC2 risk-haplotype block (blue line) relative to the microdeletion (yellow box) and the READ1 STR (purple line) it
encompasses. Exons are numbered.
(C) Alignment of READ1 and flanking sequence from human, chimpanzee, and gorilla DCDC2. READ1 is highlighted for all three
species. Note the relative conservation of the flanking sequence compared to READ1.SK-N-MC (ATCC HTB-10). Immunoprecipitation with the
a-ETV6 antibody showed marked enrichment of the
READ1 amplicon over the no-antibody control, but not
for the control amplicon derived from the gene encoding
b-actin (ACTB [MIM 102630]), in both cell lines (Figures
2C and 2D and Tables S6A and S6B). Immunoprecipitation
with the positive-control antibody, which recognizes a his-
tone H3 variant abundant in actively transcribing genes,
enriched both amplicons, as would be expected from two
actively transcribing genes (DCDC2 and ACTB). These re-
sults demonstrate that ETV6 binds the READ1 region
in vivo in both a human lymphoblastoma and a human
neuroepithelioma cell line.The DCDC2 Risk Haplotypes Show a Synergistic
Genetic Interaction with a Known RD Risk Haplotype
in KIAA0319
Together with our previous findings, these data implicate
READ1 as a regulatory element. Luciferase assays suggest
that READ1 is capable of modulating expression from
the DCDC2 promoter, but it might regulate other
genes.14 A three-marker risk haplotype encompassing the
50 half and upstream sequence of KIAA0319 has been
consistently associated with RD and lowered reading
performance.19,28–30 Expression of KIAA0319 is lower in
several cell lines that have this haplotype than in cell lines
that do not.31 Additionally, expression from the KIAA0319
promoter in two human neural cell lines (including SK-
N-MC) is reduced by the minor allele of a SNP that resides
in the KIAA0319 promoter and that is associated with this
haplotype.32 We therefore questioned whether READ1
might interact genetically with the KIAA0319 risk haplo-
type and examined the effect of having both a DCDC224 The American Journal of Human Genetics 93, 19–28, July 11, 2013risk haplotype (CGCGAG or GACGAG) and the
KIAA0319 risk haplotype on several reading, language,
and cognitive measures. Strikingly, subjects positive for
risk haplotypes in both genes showed markedly worse
mean performance (up to 0.40 SD) on nearly all measures
examined (Figure 3A). This reduction in performance in
subjects with a risk haplotype in both genes is, for most
of the phenotypes examined, greater than the sum of those
in subjects with a risk haplotype in only one gene or the
other, indicating a synergistic interaction between these
two variants. This result corroborates a previous report,
which provided statistical evidence that DCDC2 and
KIAA0319 interact to influence RD risk.33Discussion
Given the remarkable similarity between the human
exome and those of other higher primates, it has been
hypothesized that rapidly evolving regulatory elements
are responsible for the large phenotypic differences that
we observe. The ENCODE Consortium’s recently pub-
lished results, which showed most of the noncoding
genome to be active and much of the active proportion
to be regulatory, lend circumstantial support to this
hypothesis.34 Here, we report evidence of just such a
regulatory element affecting reading and language, two
exclusively human phenotypes. READ1 appears to have
expanded rapidly from gorilla to human, although the
sequence flanking it is quite conserved (Figure 1C), and
its presence, length, and sequence vary widely among pri-
mate species (Figure S2).
READ1 specifically binds ETV6, a transcription factor
encoded by a proto-oncogene and also known as TEL
Figure 2. READ1 Binds the Transcription
Factor ETV6
(A and B) SILAC results for Raji and HeLa
cells and a two-dimensional interaction
plot of enrichment for forward and reverse
experiments.
(C and D) ChIP results for the Raji (C) and
Sk-N-MC (D) cell lines. ‘‘a-H3’’ is the posi-
tive-control antibody to a histone H3
variant enriched in actively transcribing
genes, and ‘‘b-actin’’ is the control ampli-
con from ACTB, which encodes b-actin.
Error bars represent the SD among three
replicates. The single asterisk represents a
p value below 0.05, and the double aster-
isks represents a p value below 0.01 (one-
tailed t test; see Tables S6A and S6B).(translocation ETS leukemia). ETV6 (MIM 600618) is
known to be essential for hematopoiesis in bone
marrow.35 It is best known, however, for its tendency to
form oncogenic fusions—often with RUNX1 (MIM
151386)—which are frequently seen in leukemia.36
Because much of the study of ETV6 has been focused on
these hematopoietic and oncogenic capacities, less is
known about its role in other tissues, including the brain.
Expression microarray showed ETV6 to be expressed in
both the fetal and the adult human brain (data are acces-
sible at the NCBI Gene Expression Omnibus, accession
numbers GDS3113 and GSE7905, see Web Resources),37
and we confirmed ETV6 accumulation in the cell lines
we used for the ChIP experiments in this study by immu-
noblot analysis (Figure S4). Interestingly, an in situ hybrid-
ization study done in mice as part of the Brain Gene
Expression Map project38 (see Web Resources) showed an
intriguing pattern of Etv6 expression in the murine brain.
At embryonic day 15, Etv6 expression appeared specifically
upregulated in the ventricular zone, which houses pro-
liferating neuronal precursors that will eventually migrate
to the cerebral cortex.39 At postnatal day 7, this pattern
of specifically higher expression shifted to the cerebral
cortex. Etv6 expression then appeared to decrease and
become regionally nonspecific in the adult mouse
brain. This pattern, which mirrors the developmental
expression pattern of the KIAA0319 mouse ortholog
(D130043K22Rik),31 suggests that Etv6 is expressed in
migrating neurons during cortical development. If this
is true, and if it is recapitulated in humans, it indicates
that ETV6 had an established presence in migratory neu-The American Journal of Hurons before READ1 appeared in the
genome and that READ1 was thus
allowed to effectively commandeer
ETV6—that is, to target ETV6 regula-
tion to one or more genes that it
did not regulate previously. If these
target genes are themselves involved
in neuronal migration, like DCDC2
and KIAA0319, this would giveREAD1 alleles the potential to affect the neuronal migra-
tion process.
ETV6’s effect on transcription is generally repressive
via recruitment of a corepressor complex.40 Monomeric
ETV6 has essentially no affinity for its binding sequence;
it must at least dimerize to bind DNA.41 There is evidence
that ETV6 polymerizes in vivo and that the length of the
polymer is dependent on the number and spacing of bind-
ing sites.42 This property suggests the possibility that
different alleles of READ1 bind ETV6 polymers of different
lengths depending on the number of suitably spaced ETV6
binding sites and that these differences change the regula-
tory power of the complex (Figure 3B). Supporting this idea
is the structural similarity of alleles 5 and 6: relative to the
most common allele, both have the same GGAA insertion
in repeat unit 2 (Table S4). GGAA is the core binding
sequence of ETV6,41 and this insertion could recruit an
additional ETV6 monomer to the complex.
However, whether ETV6 represses transcription in this
context and which genes it targets are uncertain. Our pre-
viously reported luciferase assays appear to indicate that
some READ1 alleles activate transcription from the
DCDC2 promoter and that alleles with very different struc-
tures (e.g., 3 and 5, Table S4) activate transcription to a
similar extent.14 However, READ1’s genetic interaction
with the KIAA0319 risk haplotype and its dramatic effect
on phenotype suggest KIAA0319 as a target gene in vivo.
The KIAA0319 risk haplotype is known to be associated
with reduced KIAA0319 expression, at least in human
neuronal cell lines (including SK-N-MC), suggesting that
it could segregate with a promoter or promoter-proximalman Genetics 93, 19–28, July 11, 2013 25
Figure 3. The DCDC2 Risk Haplotypes
Interact Synergistically with the
KIAA0319 Risk Haplotype
(A) Effect of genotype for the DCDC2 and
KIAA0319 risk haplotypes on various
reading, language, and cognitive pheno-
types (described in detail in Table S1).
Data points represent the mean of each
group and were converted to a Z score rela-
tive to the mean of the ALSPAC sample
population. Units of the y axis are frac-
tions of a SD. Abbreviations are as follows:
PD, phoneme-deletion task; Reading7,
single-word reading at age 7 years; NW
Reading, nonword reading at age 9
years; Spelling7 and Spelling9, spelling at
ages 7 and 9 years, respectively; WOLD,
Wechsler Objective Learning Dimensions
verbal comprehension task; and NWR:
nonword-repetition task.
(B) Hypothetical model of differential
effects of READ1 alleles. ETV6 monomers
must at least homodimerize through their
pointed (PNT) domains to bind DNA
through their ETS domains, and they are
thought to homopolymerize in vivo.
Indels of READ1 repeat units could change
the size of the ETV6 polymer and thus
affect target-gene expression.variant that increases repression (or decreases activation)
by READ1 and thereby result in reduced gene expression
and possible phenotypic consequences. That we also
observed reduced IQ with the DCDC2-KIAA0319 interac-
tion (Figure 3A) might reflect pleiotropic pathology at
the cellular level (e.g., disrupted neuronal migration), or
it might simply reflect the importance of language in
measuring IQ. READ1 genotyping in all members of the
ALSPAC cohort and subsequent combinatorial analysis,
together with chromatin-conformation experiments, will
further illuminate READ1’s mechanism of action.
The effects of the DCDC2 and KIAA0319 risk haplotypes
on reading and cognitive phenotypes appear to be syner-
gistic. This lends credence to the ‘‘phantom-heritability’’
hypothesis, which explains the so-called missing heritabil-
ity of continuous traits as resulting from nonadditive inter-
actions between risk variants.43 Also supporting this idea is
the fact that although subjects with theDCDC2 risk haplo-
types showed reduced average performance on phenotypic
measures, the SDs for these measures were generally
similar to those of subjects negative for these risk haplo-
types (Table 2). This implies that the magnitude of effect
of the risk haplotypes on phenotype lies on a continuum
and is dependent on other, interacting risk variants, as26 The American Journal of Human Genetics 93, 19–28, July 11, 2013well as environmental and stochastic
factors. This is what would be intui-
tively expected of a polymorphic
regulatory element. Confirming or
refuting this hypothesis will require
much further work, but if it is found
to be true, it could add to the inherentcomplexity regarding the predictive value of genetic
variants for continuous traits. Finally, these results might
suggest a partial explanation for the missing efficacy
of genome-wide association studies (GWASs). If rapidly
evolving regulatory elements are indeed substantially
responsible for continuous phenotypic variation, they
would be expected, like READ1, to show a higher degree
of polymorphism than the average SNP. This would make
identifying them difficult by standard single-marker ana-
lyses in GWASs, reinforcing the importance of multi-
marker, pathway, and gene-gene interaction analyses in
the study of complex traits.
Supplemental Data
Supplemental Data include 4 figures and 11 tables and can be
found with this article online at http://www.cell.com/AJHG.
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